Inside Director Jin Yanggon Increases Shareholding in HLB Genesys Through Share Purchase

Inside Director Jin Yanggon of bio-healthcare materials specialist HLB Genesys (187420) disclosed updated shareholding information on July 1, revealing he added 27,000 shares purchased via a market transaction on June 29. His total HLB Genesys shareholding rose to 764,300 shares, increasing his ownership stake from 2.25% to 2.33%. As of 11:30 AM on July 2, HLB Genesys' stock was trading at 1,983 won, down 2.07% from the previous day. Recent financial results show the company reported total assets of 135.8 billion won, liabilities of 81.1 billion won, and equity of 54.7 billion won. Revenue reached 43.4 billion won, with operating profit of 1.2 billion won and net profit of 22.9 billion won. HLB Genesys, a KOSDAQ-listed firm since March 29, 2000, is a basic pharmaceutical materials manufacturer.